12:00 AM
Apr 22, 2013
 |  BC Week In Review  |  Financial News  |  Proposed Offerings

Northwest Biotherapeutics proposes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md.
Business: Cancer
Date announced: 4/18/13
Type: Direct public...

Read the full 50 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >